We have previously reported the presence of activated (HLA-DR+) T cells in multiple myeloma (MM) patients. These cells produce high amounts of interleukin (ILI-2 and interferon (IFN)-y and generate a potent antiplasma cell activity after appropriate in vitro stimulation, but they are unable in vivo t o hold in check the disease. Activated T cells are highly susceptible t o apoptosis, a form of programmed cell death involved in the modulation of immune responses and regulated by molecules such as Fas (CD951 and bcl-2. The aim of this study was t o determine the expression of Fas and bcl-2 antigens and the susceptibility t o apoptosis in T cells of MM patients. Fas+ cells were significantly higher, whereas bcl-2+ cells were significantly lower in MM patients than in the controls. MM patients with the highest number of HLA-DR+ T cells showed the highest Fas and the lowest bcl-2 expression. Two-color cytofluorometric analysis confirmed apoptosis is restricted to a proportion of cells in mixed populations. Under these conditions, a reliable identification of apoptotic cells requires a combination of assays and confirmation by the qualitative analysis of DNA fragmentation by gel electrophoresis.
We have previously reported the presence of activated (HLA-DR+) T cells in multiple myeloma (MM) patients. These cells produce high amounts of interleukin (ILI-2 and interferon (IFN)-y and generate a potent antiplasma cell activity after appropriate in vitro stimulation, but they are unable in vivo t o hold in check the disease. Activated T cells are highly susceptible t o apoptosis, a form of programmed cell death involved in the modulation of immune responses and regulated by molecules such as Fas (CD951 and bcl-2. The aim of this study was t o determine the expression of Fas and bcl-2 antigens and the susceptibility t o apoptosis in T cells of MM patients. Fas+ cells were significantly higher, whereas bcl-2+ cells were significantly lower in MM patients than in the controls. MM patients with the highest number of HLA-DR+ T cells showed the highest Fas In particular, it is intriguing that peripheral blood counts of HLA-DR+ T cells (including Id-reactive cells) are negatively correlated with diagnosis and disease status. ' Activated T cells have been reported to display an increased susceptibility to apoptosi~,~." a form of programmed cell death occurring in the absence of inflammation that leads to the fragmentation of genomic DNA." Accumulating evidence indicates that apoptosis is involved in the regulation of cellular immune response^.'*^*'^ A number of molecules that might regulate apoptosis have been identified in T cells, including the Fas (CD95) antigen and the bcl-2 protein." Molecular cloning has shown that the former belongs to the tumor necrosis factor receptor (TNF-R)/nerve growth factor receptor (NGFR) f a m i l~'~; its engagement by specific monoclonal antibodies (MoAbs) transduces apoptotic signals that result in the death of Fas+ cell^.'^ The protein coded by the bcl-2 protoonocogene was originally discovered to be overexpressed in follicular lymphomas at the breakpoint of t(14; 18) chromosomal transl~cation.'~ It is widely distributed in lymphoid and hematopoietic cells and promotes cell survival by preventing apoptosis. apoptosis is restricted to a proportion of cells in mixed populations. Under these conditions, a reliable identification of apoptotic cells requires a combination of assays and confirmation by the qualitative analysis of DNA fragmentation by gel electrophoresis.
In this study we have investigated in purified T cells of multiple myeloma (MM) patients the expression of Fas and bcl-2 antigens and the susceptibility to spontaneous and triggered apoptosis using two independent methods and DNA gel electrophoresis. The aim of this work was to determine to what extent the activation state occurring in MM might influence the expression of Fas and bcl-2 antigens and the susceptibility to apoptosis in peripheral blood T cells. Patients were not on antibiotics, did not have infections, and had not received transfusions for at least 10 days before the study. As the median age of the MM patients was above 50 years and Fas+, CD45RO+ T cells have been reported to increase with advancing age,'' the control group was age-matched and consisted of 30 normal volunteers. Experiments were designed in such a way that cells from at least one normal control were always studied simultaneously with T cells from the patients. Cell preparation. Peripheral blood mononuclear cells were obtained by density gradient centrifugation (Ficoll-Hypaque) of heparinized venous blood.' Monocytes were extensively removed to prevent the clearance of apoptotic cells by phagocytosis." The carbonyl-iron method and the lysosomotropic compound L-leucine methyl ester were used to deplete monocytes, as previously reported.2 T lymphocytes were isolated by rosetting with sheep erythrocytes at 29°C for 1 hour to exclude the majority of CD3-, CD2+ rosette-forming cells. Cells forming rosettes (T lymphocytes) were isolated from nonrosetting cells on a Ficoll-Hypaque density gradient.
MATERIALS AND METHODS

Patienfs
The standard medium was RPMI 1640 (GIBCO, Milan, Italy) containing 2 mmollL glutamine, penicillin (100 UlmL), and streptomycin (100 pg/mL). Propidium iodide (PI) and saponin were from Sigma (Milan, Italy); recombinant human IL-2 (1 8 X 10' IWmg specific activity) was from Eurocetus (Milan, Italy).
Antibodies and reagents.
Flow cytotnetry. Cytofluorometric analysis of surface antigens (Fas, CD45, HLA-DR) was performed on intact cells as previously bcl-2 expression was evaluated by cytoplasmic cytofluorometric analysis of saponin-permeabilized T cells. When analyses of HLA-DR and bcl-2 expressions were performed together, the former was performed before permeabilization. Briefly, T cells were incubated with PE-conjugated anti-HLA-DR for 30 minutes on ice. After two washes, cells were fixed in 0.25% paraformaldehyde in phosphate-buffered saline (PBS), pH 7.4, for 20 minutes at room temperature (RT) and then permeabilized in 0.1% saponin in PBS (pH 7.4) for 5 minutes on ice. After washing with PBS with 0.01% saponin, cells were incubated with 0.5 pg/mL anti-bcl-2 MoAb in PBS for 30 minutes on ice. After further washing, cells were analyzed with a fluorescence-activated cell sorter (FACS; FACScan, Becton Dickinson). FITC-and PE-conjugated mouse myeloma proteins of the appropriate subclasses were used as negative controls. Five thousand events were accumulated and analyzed for fluorescence. On the basis of the control sample, contour plots were divided into quadrants to identify unstained cells (quadrant 3), cells stained by both MoAbs (quadrant 2), and cells stained by only a single MoAb (quadrants 1 and 4).
Cell treatment. To evaluate spontaneous apoptosis, T cells were routinely incubated at 1 X 106/mL in RPMI + 1% fetal calf serum (FCS) in 24-well plastic tissue culture plates (Costar Italia szl, Milan, Italy) at 37°C for 18 hours in 5% CO2. In a smaller series of 10 patients, cells were side-by-side incubated in RPMI + 1% FCS and RPMI + 10% FCS to determine the effect of higher FCS concentrations on spontaneous apoptosis. To evaluate triggered apoptosis, T cells were incubated in RPMI + 10% FCS at 37°C for 18 hours in 5% CO, in the presence of 1.5 pmol/L methylprednisolone (MP) or anti-Fas MoAb (1500 final dilution). At the end of the cultures, cells were split for measurement of apoptosis. In some experiments, normal T cells were exposed to 6 Gy from a 6oCo radiation source as a positive control for apoptosis.'" Measurement of apoptosis. Apoptosis was assessed with an immunocytofluorometric method detecting changes in morphology and the decreased expression of surface molecules,*' and with the cytofluorometric analysis of hypodiploid DNA labeled with PL2* The immunocytofluorometric method identifies apoptotic cells on the basis of peculiar forward (FSC) and side light scatter (SSC) changes, reflecting their smaller size and their increased granularity, and on the basis of decreased expression of surface molecules such as CD45.2' This method allows the identification of apoptotic cells in mixed populations as well as their immunophenotyping. FACS settings were specifically focused on the lymphocyte region by incrementing the amplification gain of the FSC photodiode and both the amplification gain and the excitation voltage of the SSC photomultiplier, as to delimit the regions of viable (Reg V) and apoptotic cells (Reg A) (see Figs 2 and 5) . In some experiments, cultured T cells were double-stained for CD45MLA-DR and CD4/CD8 to determine simultaneously the proportion of apoptotic cells and the expression of these antigens in Reg V and Reg A.
P1 staining was performed with a modification of the method by Table 1) . Correlation between Fas, bcl-2, and HLA-DR expression. MM T cells are highly heterogenous in terms of HLA-DR expression.',* Fas and bcl-2 expressions were evaluated in MM cells divided into four groups according to the proportion of HLA-DR+ T cells: group A, less than 10%; group B, 10% to 20%; group C, 20% to 30%; and group D, greater than 30%; Table 1 ). The percentage of Fas+ cells was already significantly higher than the controls in groups A and B; it increased further in group C and reached the highest value in group D. Expression of bcl-2 was not different in groups A and B; it was significantly lower in group C and reached the lowest value in group D. These data indicate that MM cells with the highest proportion of circulating HLA-DR+ T cells also present the highest and the lowest proportion of Fas+ and bcl-2+ cells, respectively.
Two-color cytofluorometric analysis was performed on freshly isolated T cells to further characterize in individual cells the relationships between HLA-DR, Fas, and bcl-2 antigens. Samples from two representative MM patients are shown in Fig 1 to demonstrate the inversion correlation between Fas and bcl-2 expression.
Increased susceptibility to apoptosis in MM. Susceptibility to apoptosis was then investigated in MM T cells with dysregulated Fas and bcl-2 expression. In a first series of experiments, susceptibility to spontaneous apoptosis was investigated after 18-hour incubation in RPM1 + 1% FCS at 37°C. Percentages of apoptosis cells were significantly higher in MM than in the controls (Table 2) . Similar results were observed in 10 experiments where MM and normal T cells were incubated in RPM1 + 10% FCS, and percents of apoptotic cells were determined with the immunocytometric method (MM, 25% 5 6%; controls, 9% 2%; P = .02).
In a second series of experiments, susceptibility to triggered apoptosis was investigated using MP and anti-Fas MoAb as apoptotic agents. Again, MM T cells displayed a higher susceptibility to apoptosis than normal T cells (Table  2) . Results from a representative MM patient are shown in Fig 2. The increased susceptibility of MM T cells to spontaneous and triggered (1.5 pmoVL MP) apoptosis was maintained over a 4-day incubation period (data not shown).
To directly evaluate HLA-DR expression in apoptotic cells, T cells were double-stained with anti-HLA-DR and anti-CD45 MoAbs, and the expression of these antigens together with cell size and granularity were compared in Reg A and Reg V of the same sample. Results from a representative experiment are shown in Fig 3. T cells from Reg A showed the typical features of apoptotic cells, including smaller size (Fig 3A) , increased granularity (Fig 3B) , and decreased CD45 expression ( Fig  3C) :' These cells also showed increased HLA-DR expression compared with T cells from Reg V (Fig 3D) .
Some experiments were performed to determine whether cells gated in Reg A presented the typical DNA fragmentation of apoptotic cells. These cells were enriched by density gradient centrifugation onto a Ficoll-Hypaque gradient as previously reported." Dense cells recovered from the pellets and light cells recovered at the interphase were reanalyzed by FACS and fell in Reg A and Reg V of unseparated samples, respectively. In six experiments, the percentages of apoptotic and viable cells were 15% ? 3% and 78% t 4%, respectively, in unseparated samples; 6% ? 2% and 82% 2 3%, respectively, in the light cell fraction (Reg V); and 76% t 3% and 10% f l%, respectively, in the dense cell fraction (Reg A). Both fractions were subjected to DNA extraction and gel electrophoresis. As positive controls, DNA extracted undergone DNA fragmentation. Similar results were obfrom normal T cells exposed to 6 Gy radiation and from served when DNA was extracted from MM T cells treated thymocytes were included (Fig 4) . The Cells were incubated at 37°C for 24 hours in medium + 1% FSC in the presence or absence of SO IU/mL 1L-2. The proportion of apoptotic cells was decreased in the presence of IL-2 (medium, 30% -t 13%; 1L-2, 7 8 2 2%: P = .02; Fig S) .
DISCUSSION
This study was undertaken to evaluate the role of apoptosis in the immune dysregulation of MM T cells. We have initially investigated expression of the Fas and bcl-2 antigens, which are important regulators with opposite effects on apoptosis." MM T cells showed an increase of Fas+ and a decrease of bcl-2+ cells that became progressively more evident as the percentage of HLA-DR+ T cells increased. This distribution was opposite to that observed in the controls. where Fas is expressed by a minority (20% to 40%) and bcl-2 by the majority (greater than 80%) of resting T cells."l Normal T cells, however, can be induced in vitro to upregulate Fas and downregulate bcl-2, provided that they are subjected to a prolonged stimulation with mitogens such as phytohemagglutinin (PHA) or anti-CD3 MoAbs.'.'J.'X A chronic activation state that is likely to occur in MM, where T cells are exposed long-term to tumor cells. A two-color cytofluorometric analysis confirmed the inverse correlation between Fas. bcl-2, and HLA-DR expression in individual MM T cells.
Fas'"F'l/bcl-2'"' phenotype is thus supposed to reflect a For personal use only. on August 16, 2017. by guest www.bloodjournal.org From The next step was to determine whether the FashiF"/bcl-2'""' phenotype was associated with an increased susceptibility to apoptosis. The conventional understanding is that spontaneous apoptosis occurs in immature and activated T cells (also referred as activation-induced cell death), but not in resting T cells. However, we and others have detected a small proportion of apoptotic cells in normal T cells as well.".'X"' indicating that apoptosis is not an all-or-nothing phenomenon; rather, its magnitude distinguishes MM from normal T cells. Spontaneous apoptosis may be considered as a withdrawal mode to initiate programmed cell death (ie, apoptosis induced by deprivation of growth factors or positive cell-tocell interactions). In a second series of experiments. susceptibility to apoptosis induced by a triggering mode was evalu- In ERV and VZV infections, apoptosis is the major mechanism by which the bulk of T cells with antiviral activity are rapidly removed once the infection has been successfully cleared. In AIDS patients. where the infection is not cleared, apoptosis is believed to contribute to the progressive establishment of their immunodeficiency.3si" MM is another disease where, despite the presence of specific interactions with the tumor cells. there is no spontaneous resolution. and T cells are subjected to a repetitive stimulation leading to chronic activation and enhanced susceptibility to apoptosis. Apoptosis is one of the mechanisms responsible for the es-tablishment of peripheral tolerance and clonal inactivation of mature functional T The nonresponsive state may be maintained as long as T cells are exposed to the If this occurs in vivo, the immune system is depleted of effector T cells, which are among the best candidates to specifically interact with tumor cells. This may be one of the mechanisms exploited by tumor cells to weaken and escape T cell-mediated immunosurveillance. Studies are currently in progress to determine any correlation among apoptosis, tumor progression, and the clinical outcome in MM.
The molecular mechanisms by which tumor cells make T cells more susceptible to apoptosis have not yet been identified. One possibility is that tumor cells cannot provide the accessory signals required to fully activate T cells." In their absence, TCR occupancy may predispose to apopt~sis.~' Exogenous cytokines have been used to provide these accessory signals. This is one of the rationales supporting the use of cytokines such as IL-2 in clinical trial^.^' Spontaneous apoptosis was prevented in MM T cells by the addition of exogenous IL-2. It has recently been demonstrated that IL-2 can sustain bcl-2 expression even in extensively activated T cells,24 pointing to bcl-2 upregulation as a mechanism by which IL-2 exerts its antiapoptotic activity. Interestingly, high levels of serum IL-2 are powerful predictors of longer survival in MM," raising the possibility that prevention of T-cell apoptosis is a mechanism by which endogenous IL-2 positively influences the disease evolution.
In conclusion, T cells in MM are in a chronic activation state characterized by a Fash'gh/b~1-2'"" phenotype. This places them in a particular situation: on the one hand, they have a less stringent need of accessory signals to produce IL-2 and proliferate fully (at least in on the other hand, they reopen their death program and become more susceptible to apoptosis." Any immunotherapy-based approach should, therefore, be carefully designed to trigger antitumor activity rather than apoptosis.
